Shamburg News · 8-K filed Nov 13, 2026, 7:50 AM EST

TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Corporate Update

HURA · TuHURA Biosciences, Inc./NV

  • Earnings
  • Financing
  • Other event
  • Materiality: medium

On November 13, 2026, TuHURA Biosciences, Inc. reported financial results for the three months ended September 30, 2026, and provided a corporate update in a press release furnished as Exhibit 99.1. The filing states cash and cash equivalents of $1.9 million at September 30, 2026, and research and development expenses of $3.7 million for the quarter versus $5.0 million a year earlier. General and administrative expenses were $2.0 million versus $1.6 million, and the Company received $9.2 million in gross proceeds on its Parkview credit facility as of September 30, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001193125-26-459311.

Written from the filing by Shamburg Markets. Figures are as reported by the company.